A Phase I, single-dose, randomized, double-blind, double-dummy, crossover study investigating abuse liability assessment of eslicarbazepine acetate in healthy male and female recreational sedative users
Latest Information Update: 22 Sep 2017
Price :
$35 *
At a glance
- Drugs Eslicarbazepine acetate (Primary) ; Alprazolam
- Indications Partial epilepsies
- Focus Pharmacodynamics
- Sponsors Sunovion Pharmaceuticals
- 22 Sep 2017 New trial record